LONGEVITY.TECHNOLOGY
Does gene silencing technology hold the key to cellular rejuvenation? Junevity founder explains how developments in siRNA therapeutics are enabling new ways to return cells to healthier states.
Previous
Previous
PHARMACEUTICAL EXECUTIVE
Next
Next